The report " Global Epigenetics Market, By Product Type (Consumables and Instruments), By Application (Oncology, Developmental Biology, Drug Development, Metabolic Disorders, and Other), By End User (Academic & Research Institute, Pharmaceuticals & Biopharmaceutical Companies, and Contract Research Organization) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030”
Key Highlights:
• In January 2017, Illumina went into a concurrence with Koninklijke Philips (Netherlands) to coordinate Ilumina's sequencing frameworks with Philips' IntelliSpace Genomics clinical informatics stage for oncology.
• In June 2017, Illumina introduced Extended RAS Panel, a NGS pack
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Epigen...
Key Market Insights from the report:
The Global Epigenetics Market accounted for US$ 1.4 billion in 2020 and is estimated to be US$ 4.3 billion by 2030 and is anticipated to register a CAGR of 11.5%. The epigenetics market is segmented on the basis of product, application, end user and region.
• By product, the global epigenetics has been segmented consumables and instruments.
• By Application, the Global Epigenetics Market is segmented into oncology, developmental biology, drug development, metabolic diseases and other.
• By end user the global epigenetics market has been segmented into academic & research institute, pharmaceuticals & biopharmaceutical companies, and contract research organizations.
• By region, the Global Epigenetics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the epigenetics market in terms of revenue, due to the developed healthcare system and health awareness among people.
Competitive Landscape:
Key players operating in the global market of epigenetics include Illumina Inc., Thermo Fisher Scientific Inc., Merck Millipore Limited, Bio-Rad Laboratories, Inc., Qiagen Inc., Zymo Research Corporation, Diagenode s. a., Enzo Life Sciences, Inc. and New England Biolabs Inc.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Contact Us:
Sales
Prophecy Market Insights
1 860 531 2701